WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
What is the latest Consolidated Net Profit of WANBURY ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹-13 Cr |
How is Consolidated Net Profit of WANBURY Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | -45.44 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-13 Cr | - | |
Compare Consolidated Net Profit of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,151.2 Cr | -3.8% | 20.4% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -3.8% |
20.4% |
24.3% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses